Drug Information

General Information
Drug ID
DR00393
Drug Name
Atomoxetine
Synonyms
(-)-Tomoxetine; (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine; Atomoxetine (INN); Attentin (TN); Strattera (TN); Tomoxetin (TN); Tomoxetina; Tomoxetina [Spanish]; Tomoxetine; Tomoxetine [INN]; Tomoxetinum; Tomoxetinum [Latin]
Drug Type
Small molecular drug
Indication Attention deficit hyperactivity disorder [ICD11: 6A05] Approved [1]
Structure
3D MOL 2D MOL
Formula
C17H21NO
Canonical SMILES
CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2
InChI
InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1
InChIKey
VHGCDTVCOLNTBX-QGZVFWFLSA-N
CAS Number
CAS 82248-59-7
Pharmaceutical Properties Molecular Weight 255.35 Topological Polar Surface Area 21.3
Heavy Atom Count 19 Rotatable Bond Count 6
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2
XLogP
3.7
PubChem CID
54841
PubChem SID
103189006 , 104024503 , 104305955 , 11114266 , 117535667 , 126582523 , 126629698 , 126655720 , 126684045 , 126723363 , 129474852 , 134338009 , 134358577 , 135030248 , 137171620 , 140098827 , 143495940 , 14749997 , 15196878 , 152101253 , 152234173 , 160845669 , 160963637 , 163773677 , 175265837 , 178103695 , 179151249 , 196105295 , 223540968 , 223682620 , 223992935 , 225207579 , 226420765 , 3249493 , 34718779 , 46506160 , 47510014 , 48179683 , 50070867 , 51091800 , 57313676 , 74924255 , 8183809 , 85731218 , 85788174 , 92714045
ChEBI ID
CHEBI:127342
TTD Drug ID
D04CRN
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Atomoxetine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.